Clearside Biomedical, Inc. (CLSDQ)
0.79
-0.11
(-12.22%)
USD |
OTCM |
Dec 05, 16:00
Clearside Biomedical Total Liabilities (Quarterly): 65.59M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 5.986B |
| Eli Lilly & Co. | 91.08B |
| Mersana Therapeutics, Inc. | 122.22M |
| Inspire Medical Systems, Inc. | 141.26M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.64M |
| Shareholders Equity (Quarterly) | -53.95M |
| Debt to Equity Ratio | -1.142 |
| Current Ratio | 2.980 |
| Net Debt Paydown Yield | -13.49% |